Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In the Medical Assistance business, results benefited from contracts for services from major overseas non-life insurers and the Ministry of Health, Labour and Welfare's EMIS service, among other factors. In the Life Assistance business, results benefited from contract reviews driven by growth in the number of cardholders.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥964 million (YoY +6.4%) |
| Operating profit | ¥18 million |
| Ordinary income | ¥27 million (YoY +231.9%) |
| Profit attributable to owners of the parent | ¥18 million (YoY +0.3%) |
| Net income per share | ¥7.52 |
| Equity ratio | End of the current fiscal period 47.7% / End of previous period 48.7% |
| Total assets | ¥3,906 million |
| Net assets | ¥1,893 million |
| Full-year earnings forecast | Net Sales ¥4,000 million (YoY +7.7%) / Operating profit ¥200 million (YoY +108.1%) / Ordinary income ¥200 million (YoY +93.1%) / Profit attributable to owners of the parent ¥140 million (YoY +37.4%) / Net income per share ¥55.57 |
| Annual Dividend Forecast | ¥9 → Undecided（Undecided） |
| Segment revenue | Medical assistance business ¥833,349 thousand (YoY +5.7%), Life assistance business ¥130,964 thousand (YoY +11.0%) |
| Segment profit | Medical assistance business ¥121,125 thousand (YoY +28.7%), Life assistance business ¥33,768 thousand (YoY +61.4%) |
| Depreciation and amortization | ¥10,186 thousand |
| Impairment loss | None applicable (material impairment loss related to non-current assets) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥10 thousand / Extraordinary loss No applicable matters. |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No (no companies newly consolidated or excluded) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 2,519,600 shares |
| Treasury Shares at Period-End | 466 shares |
| Factors Behind Changes in Business Performance | In the Medical Assistance business, results benefited from contracts for services from major overseas non-life insurers and the Ministry of Health, Labour and Welfare's EMIS service, among other factors. In the Life Assistance business, results benefited from contract reviews driven by growth in the number of cardholders. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Medical Assistance business, results benefited from assistance services contracted by major overseas non-life insurers and the Ministry of Health, Labour and Welfare's EMIS (Emergency Medical Information System) service. In the Life Assistance business, sales increased mainly because contracts were reviewed in response to growth in the number of cardholders among existing business partners.